Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShield Thera Share News (STX)

Share Price Information for Shield Thera (STX)

Share Price is delayed by 15 minutes
Get Live Data
5.75    -0.10 (-1.71%)
Bid:
5.70
Ask:
5.80
Spread: 0.10 (1.754%)
Market Cap: £61.50m
STX Live PriceLast checked at - London Stock Exchange

Intraday Shield Thera Share Chart

Shield Thera News

TRADING UPDATES: Aston Martin CEO ups stake; Alkemy's lithium deal
3 Oct 2023

TRADING UPDATES: Aston Martin CEO ups stake; Alkemy's lithium deal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Shield Therapeutics completes USD20 million SWK financing
3 Oct 2023

Shield Therapeutics completes USD20 million SWK financing

(Alliance News) - Shield Therapeutics PLC on Tuesday said it has now completed its USD20 million senior secured debt facility from SWK Funding LLC.

UPDATE: Shield Therapeutics completes GBP5 million share placing
28 Sep 2023

UPDATE: Shield Therapeutics completes GBP5 million share placing

(Alliance News) - Shield Therapeutics PLC on Thursday announced steps to improve its financial situation, as it revealed a slightly reduced loss in th...

Shield Therapeutics raises funds for US sales push as loss narrows
28 Sep 2023

Shield Therapeutics raises funds for US sales push as loss narrows

(Alliance News) - Shield Therapeutics PLC on Thursday announced steps to improve its financial situation, as it revealed a slightly reduced loss in th...

IN BRIEF: Shield Therapeutics changes reporting currency to US dollars
6 Sep 2023

IN BRIEF: Shield Therapeutics changes reporting currency to US dollars

Shield Therapeutics PLC - Gateshead Quays, England-based commercial stage pharmaceutical company focused on the commercialisation of its oral therapy ...

CORRECT: Biogens, Sage Therapeutics postpartum depression drug okayed
6 Aug 2023

CORRECT: Biogens, Sage Therapeutics postpartum depression drug okayed

(Correcting the name of Sage Therapeutics Inc. Please ignore incorrect coding of Shield Therapeutics PLC.)

Biogens, Sage Therapeutics postpartum depression treatment approved
6 Aug 2023

Biogens, Sage Therapeutics postpartum depression treatment approved

(Alliance News) - The US Food & Drug Administration has approved Zurzuvae, zuranolone, 50 mg for adults with postpartum depression, Sage Therapeutics ...